Ann: Quarterly Activities Report and Appendix 4C, page-59

Are you serious?? Have a re-think on what you just said.

This guy, or any of the management, have no way of taking this to a meaningful market - this is proven - ie the recent revenue.

The board and management know this - “managing a startup through to a sale to Pfizer” sounds a lot better on LinkedIn. These boys are happy as can be with 14c. Pfizer will, and can, take it to market. An RnD role also for the boys no doubt, why not.

This goose is done, I will be shocked if a No vote gets though, and if it does, it needs total re-investment with a new team. Which brings another 5 year outlook……bla bla bla, starting from sub 3 cent.

wake up football fans, your team is simply no good